Variable density braid stent

• US 8,506,619 B2
• Filed: 07/14/2010
• Issued: 08/13/2013
• Est. Priority Date: 12/22/2003
• Status: Expired due to Term

• Current Assignee: Stryker European Operations Holdings, LLC (Stryker Corporation)
• Original Assignee: Stryker Corporation, Stryker Nv Operations Limited (Stryker Corporation)
• Inventors: Ortiz, John, Molaei, Masoud, Musbach, Frank, Gerberding, Brent C.
• Primary Examiner(s): Isabella, David
• Assistant Examiner(s): SCHILLINGER, ANN M
• Application Number:
  US12/836,357
• Publication Number:
  US 20100280587A1
• Time in Patent Office: 1,126 Days
• Field of Search: 623 111- 154
• US Class Current: 623/1.16
• CPC Class Codes: A61F 2/90 characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2002/823 Stents, different from stent-grafts, adapted to cover an aneurysm
• CPC Class Codes: A61F 2250/0015 differing in density or specific weight
• CPC Class Codes: A61F 2250/0023 differing in porosity
• CPC Class Codes: A61F 2250/0048 differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
• CPC Class Codes: D04C 1/06 Braid or lace serving particular purposes

Abstract

A stent comprises at least one stent member woven to form a substantially tubular body that defines a flow path. The tubular body comprises a first region and a second region. In the first region the at least one stent member defines a plurality of first region openings and in the second region at least one first portion of the at least one member and at least one second portion of the at least one member are engaged together to form at least one primary strand. The at least one primary strand defines a plurality of second region openings. The at least one of the plurality of second region openings is in fluid communication with the flow path. The plurality of second region openings provide the second region with a greater porosity than the first region.

Claims

1. A stent for insertion into a patient blood vessel having an aneurysm, the stent comprising:

a substantially tubular body defining a flow path therethrough and comprising a first region and a second region,

the first region of the tubular body being positionable adjacent the aneurysm and comprising a plurality of stent members interwoven to form at least one first braid defining a plurality of first region openings,

the second region of the tubular body located immediately adjacent the first region and comprising at least one second braid, the second braid comprising at least one strand that is formed by at least two stent members from the plurality of stent members,

wherein the at least one second braid defines a plurality of second region openings,

at least one of the second region openings being larger than any of the first region openings, and

wherein the first region openings are sized to restrict passage of blood therethrough to cause stagnation of the aneurysm, and the second region openings are sized to allow substantially uninhibited blood flow therethrough.

2. The stent of claim 1, wherein at least one first region opening has an area of about 0.005 mm2 to about 0.15 mm2.

3. The stent of claim 1, wherein at least one second region opening has an area of about 0.05 mm2 to about 0.3 mm2.

4. The stent of claim 1, wherein at least two members of the first braid are braided together to form the at least one second braid.

5. The stent of claim 1, further comprising a third region comprising at least one third braid having at least one strand formed by at least four stent members, wherein the at least one third braid defines a plurality of third region openings, and at least one of the third region openings being larger than any of the second region openings.

6. The stent of claim 5, wherein the third region is immediately adjacent the second region.

7. The stent of claim 5, wherein at least one third region opening has an area of about 0.05 mm2 to about 0.3 mm2.

8. The stent of claim 1, wherein a therapeutic agent coats at least a portion of the stent.

9. The stent of claim 8, wherein the therapeutic agent comprises a genetic therapeutic agent.

10. The stent of claim 8, wherein the therapeutic agent comprises cellular material.

11. The stent of claim 8, wherein the therapeutic agent comprises a polymer coating.

12. The stent of claim 1, wherein at least a portion of the tubular body is self-expandable.

13. The stent of claim 1, wherein at least a portion of the tubular body is balloon-expandable.

14. The stent of claim 1, wherein at least one portion of the tubular body is self-expandable and another portion of the tubular body is balloon-expandable.